Hollywood's most powerful organizations released a joint statement today calling for the release of six Iranian filmmakers including director Jafar Panahi and actor Marzieh Vafamehr. Lauded as one of Iran's greatest living filmmakers, Panahi is serving a six-year jail sentence under house arrest and is banned for making any films for 20 years. He recently appeared in the critically acclaimed pseudo-documentary "This Is Not A Film" which screened at the Cannes, Toronto and New York Film Festivals. Vahamehr is an actress who was given a year in jail and 90 lashes for appearing in the 2009 film "My Tehran For Sale" (her fate is currently under appeal). Along with other filmmakers who have been imprisoned for their work, Hollywood's creative community has taken a rare stand together against these injustices.
This pundit certainly isn't one to fuel a fire for no reason, but the eyebrow raising move this morning by the usually classy New York Film Critics Circle deserves some closer scrutiny.
If you're hoping Michael Shannon lands a best actor nomination for "Take Shelter," one of the most critically acclaimed films of the year, you might be worried.
Looking back at the past decade, there hasn't been many surprises in the race to win the best actor Academy Award. By the time the New Year came around, most pundits and Academy members pretty much knew who would win taking most of the fun out of this category. And, yes, that's even before the nominations were announced. Sure, Mickey Rourke gave Sean Penn a good run at it in 2009, but the only real upset you can point to is Adrien Brody in 2003 for "The Pianist." Will 2012 provide an old fashioned horse race that seems only to be left to the supporting categories these days? It's possible, but someone's going to have to step and be a true challenger for George Clooney acclaimed role in Alexander Payne's "The Descendants."
The Academy of Motion Picture Arts and Sciences announced that 63 countries have entered potential nominees for the foreign language Oscar that will be handed out at the 84th Academy Awards this February.
The Foreign Language Committee will review all the submissions and vote for the five nominees that will be announced on Tues., Jan. 24, 2012 at 5:30 AM PT.
As the fall continues, the movies must slowly bet getting better. And coincidentally, in New York and Los Angeles at least, moviegoers will get the chance to sample the latest film from Pedro Almodovar, "The Skin I Live In," tomorrow. And while I don't think the film has any real chances for major Oscar nominations (and neither did the Spanish film committee who passed it over for foreign language film consideration), it's a twisted and out-there thriller that will shock many ticket buyers looking for something different at the multiplex.
A funny thing happened on the way to awards season for Paramount Pictures' Sundance pick-up "Like Crazy," it found a surprising new audience.
The 2011 edition of the New York Film Festival received a fine gift on Monday night when Martin Scorsese's latest film, "Hugo," debuted in a "sneak screening." The unfinished picture (reports claim there was green screen evident in a number of shots) was introduced by the master filmmaker and New York icon.
After positive notices following its debut at the Venice and Toronto Film Festivals last month, George Clooney's last directorial effort opened to the masses on Friday. Seen as a potential best picture player, the political thriller had an O.K. weekend grossing $10.4 million. But, don't judge that figure too hastily.
"Ides" first weekend was actually strikingly similar to "Michael Clayton's" first "wide" weekend (actually its second overall after debuting in 15 theaters the week before) in 2007. Both were the equivalent "second" weekends of that October and both found a similar audience reception. "Clayton" found $10.3 million in just 2,511 theaters compared to "Ides" estimated $10.4 million in just 2,199. Many believed "Clayton" had a shaky start, but the Tony Gilroy drama ended up landing seven Academy Award nominations including best picture. Moreover, Tilda Swinton was something of an upset winner in the best supporting actress category over sentimental favorite Ruby Dee ("American Gangster") and critic's charge Cate Blanchett ("I'm Not There"). "Clayton" also eventually found $49 million or what is termed a "five multiple" which basically means it played much stronger than expected. The big difference between the two pictures, so far, is their nationwide critical reception.
"Clayton" averaged an 82 on Metacritic and a 90% on Rotten Tomatoes. The film featured raves from Roger Ebert, USA Today's Claudia Puig and EW's Owen Glieberman as well as very strong notices from important Academy bellwether Kenneth Turan of the LA Times as well as Manohla Dargis of the paper of record. "Ides" found major supporters in regional critic Stephen Rea of the Philadelphia Inquirer, Glieberman and Peter Travers of Rolling Stone. Turran and the NY Times' A.O. Scott gave it mixed reviews. Currently, it has a 67 on Metacritic and an 82% on Rotten Tomatoes.
The question for "Ides" in the 2012 awards season frame revolves all around one man: director, co-screenwriter and star George Clooney. The Oscar favorite rarely campaigns for his films, but after doing very limited press and awards events for "Clayton" initially, he did a full court press right before nominations were determined in January of 2008. Whether that helped push "Clayton" into what were just five nominated pictures that year is unclear. However, without 10 guaranteed nominees this season, his popularity may be needed to foster recognition for his cast and crew in January (although we'd be shocked if Philip Seymour Hoffman doesn't make the supporting actor race without George's help). Clooney will also have his impressive leading role in Alexander Payne's "The Descendants" to campaign for (competing features seems to be a regular thing for Clooney during awards season). Normally, a studio would be calling the shots here and pushing the talent to act, but without a major monetary investment, Sony Pictures will also (and understandably) be more concerned with "Moneyball" and possibly "The Girl with The Dragon Tattoo" (Sony put up the P&A to distribute the $12.5 million budgeted drama in the U.S.). With Clooney's Smokehouse Pictures production company now based at Sony, however, it's possible the film will remain an important awards season priority on the Culver City lot. Maybe. Because, as already noted, it's all up to George.
As it's only October 10, this year's awards campaign has a lot of twists and turns to go. So, for those of you already assuming "Ides" may not find itself in the um, 5, 6, 7, 8 or 9 this year, beware of making early proclamations.*
*Unless it's about "W.E," "A Dangerous Method," "Anonymous" or "Carnage" of course.
Do you think "Ides of March" is still in the game? Share your thoughts below.
For year round entertainment commentary and awards season news follow @HitFixGregory on Twitter.
LONDON - When you first heard that Orlando Bloom was starring in the new big screen adaptation of Alexandre Dumas' "The Three Musketeers" it would be natural to assume that the former "Pirates of the Caribbean" swashbuckler would be playing one of the title heroes. Instead, Bloom is playing one of the film's main two villains, the notorious Duke of Buckingham.